Altered microRNome Profiling in Statin-Induced HepG2 Cells: A Pilot Study Identifying Potential new Biomarkers Involved in Lipid-Lowering Treatment.

Zambrano, Tomás; Hirata, Rosario D C; Hirata, Mario H; Cerda, Álvaro; Salazar, Luis A

Zambrano, Tomás; Hirata, Rosario D C; Hirata, Mario H; Cerda, Álvaro; Salazar, Luis A.

Afiliación

Zambrano T; Center of Molecular Biology and Pharmacogenetics, Scientific and Technological Bioresource Nucleus (BIOREN), Universidad de La Frontera, Temuco, Chile.
Hirata RDC; School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil.
Hirata MH; School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil.
Cerda Á; School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil.
Salazar LA; Center of Molecular Biology and Pharmacogenetics, Scientific and Technological Bioresource Nucleus (BIOREN), Universidad de La Frontera, Temuco, Chile.

Cardiovasc Drugs Ther ; 29(6): 509-518, 2015 Dec.

Article en En | MEDLINE | ID: mdl-26602562

Palabras clave

Cholesterol; Epigenetics; HepG2; Pharmacoepigenetics; Statins; miRNAs

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cardiovasc Drugs Ther Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2015 Tipo del documento: Article País de afiliación: Chile Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google